Watson Pharma Private Limited
⚠️ Moderate Risk
FEI: 3005719315 • Verna, Goa • INDIA
FEI Number
3005719315
Location
Verna, Goa
Country
INDIAAddress
1 - A Plot No A3 - A6, Verna Industrial Estate Road, Verna, Goa, India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 4/7/2011 | 61HCA32NITROFURANTOIN (ANTI-BACTERIAL) | New Orleans District Office (NOL-DO) | |
| 5/3/2010 | 60XDC17ATENOLOL (ANTI-ADRENERGIC) | 118NOT LISTED | Chicago District Office (CHI-DO) |
| 5/3/2010 | 60XDC17ATENOLOL (ANTI-ADRENERGIC) | 118NOT LISTED | Chicago District Office (CHI-DO) |
| 5/3/2010 | 60XDC17ATENOLOL (ANTI-ADRENERGIC) | 118NOT LISTED | Chicago District Office (CHI-DO) |
| 5/3/2010 | 60XDC17ATENOLOL (ANTI-ADRENERGIC) | 118NOT LISTED | Chicago District Office (CHI-DO) |
Frequently Asked Questions
What is Watson Pharma Private Limited's FDA import refusal history?
Watson Pharma Private Limited (FEI: 3005719315) has 13 FDA import refusal record(s) in our database, spanning from 5/3/2010 to 4/7/2011.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Watson Pharma Private Limited's FEI number is 3005719315.
What types of violations has Watson Pharma Private Limited received?
Watson Pharma Private Limited has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Watson Pharma Private Limited come from?
All FDA import refusal data for Watson Pharma Private Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.